Hologic Ebit from 2010 to 2025

HOLX Stock  USD 64.49  0.17  0.26%   
Hologic EBIT yearly trend continues to be fairly stable with very little volatility. EBIT is likely to outpace its year average in 2025. During the period from 2010 to 2025, Hologic EBIT regression line of annual values had r-squared of  0.44 and arithmetic mean of  779,427,750. View All Fundamentals
 
EBIT  
First Reported
1990-03-31
Previous Quarter
253.5 M
Current Value
278 M
Quarterly Volatility
158.3 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Ebit Growth Pattern

Below is the plot of the Ebit of Hologic over the last few years. It is Hologic's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
1.1B2.5B1.7B787.987.1.1B1.2B116%-31%-53%25%15%5%100%
       Timeline  

Hologic Ebit Regression Statistics

Arithmetic Mean779,427,750
Geometric Mean440,282,494
Coefficient Of Variation81.85
Mean Deviation490,228,719
Median586,400,000
Standard Deviation637,991,159
Sample Variance407032.7T
Range2.5B
R-Value0.66
Mean Square Error244317.4T
R-Squared0.44
Significance0.01
Slope88,866,185
Total Sum of Squares6105490.8T

Hologic Ebit History

20251.2 B
20241.1 B
2023987.2 M
2022787.2 M
20211.7 B
20202.5 B
20191.1 B

Other Fundumenentals of Hologic

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT1.1 B1.2 B
EBITDA1.5 B1.6 B
Ebt Per Ebit 1.01  0.92 
Ebit Per Revenue 0.17  0.17 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…